AngioDynamics, Inc. (ANGO)
NASDAQ: ANGO · IEX Real-Time Price · USD
5.87
-0.16 (-2.65%)
Apr 24, 2024, 4:00 PM EDT - Market closed
AngioDynamics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for AngioDynamics stock have an average target of 14.25, with a low estimate of 10 and a high estimate of 18. The average target predicts an increase of 142.76% from the current stock price of 5.87.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for AngioDynamics stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Hold → Buy Upgrades $12 | Hold → Buy | Upgrades | $12 | +104.43% | Apr 5, 2024 |
| Raymond James | Raymond James | Buy Maintains $12 → $10 | Buy | Maintains | $12 → $10 | +70.36% | Jan 9, 2024 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $20 → $18 | Strong Buy | Maintains | $20 → $18 | +206.64% | Jan 8, 2024 |
| Raymond James | Raymond James | Buy Maintains $13 → $12 | Buy | Maintains | $13 → $12 | +104.43% | Oct 6, 2023 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $20 → $17 | Strong Buy | Maintains | $20 → $17 | +189.61% | Oct 5, 2023 |
Financial Forecast
Revenue This Year
293.05M
from 338.75M
Decreased by -13.49%
Revenue Next Year
293.00M
from 293.05M
Decreased by -0.02%
EPS This Year
-0.50
from -1.33
EPS Next Year
-0.50
from -0.50
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 319.2M | 304.5M | 330.1M | 448.4M | 496.2M |
| Avg | 293.1M | 293.0M | 320.7M | 435.6M | 482.1M |
| Low | 265.4M | 280.3M | 308.1M | 418.5M | 463.2M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -5.8% | 3.9% | 12.7% | 39.8% | 13.9% |
| Avg | -13.5% | -0.0% | 9.4% | 35.8% | 10.7% |
| Low | -21.7% | -4.4% | 5.2% | 30.5% | 6.3% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -0.43 | -0.28 | - | 0.48 | 0.78 |
| Avg | -0.50 | -0.50 | - | 0.47 | 0.75 |
| Low | -0.56 | -0.67 | - | 0.45 | 0.73 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | - | 65.6% |
| Avg | - | - | - | - | 60.9% |
| Low | - | - | - | - | 54.6% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.